Suppr超能文献

使用利尿剂预处理并不能预防硝苯地平引起的足部容积增加。

Foot volume increase on nifedipine is not prevented by pretreatment with diuretics.

作者信息

van der Heijden Antoine G, Huysmans Frans Th M, van Hamersvelt Henk W

机构信息

Department of Medicine, University Medical Centre, Nijmegen, The Netherlands.

出版信息

J Hypertens. 2004 Feb;22(2):425-30. doi: 10.1097/00004872-200402000-00029.

Abstract

OBJECTIVE

Despite their natriuretic effects, dihydropyridine calcium-channel blockers (CCBs) often induce ankle oedema, probably due to vasodilation in the dependent legs. Since concomitant administration of frusemide does not prevent the acute increase in foot volume on nifedipine, we investigated whether diuretic pretreatment attenuates foot swelling on CCBs.

METHODS

In four separate experiments, 10 healthy volunteers received: (i) 20 mg of nifedipine without active pretreatment (pretreatment with placebo only); (ii) 20 mg of nifedipine after 5 days' treatment with amiloride 5 mg twice daily; (iii) 20 mg of nifedipine after 5 days' treatment with chlorthalidone 50 mg once daily; and (iv) no active drugs (pretreatment with placebo and placebo in place of nifedipine) as the control. Foot volumes were measured using an accurate water displacement technique (intra-individual coefficient of variance 0.27%).

RESULTS

Amiloride and chlorthalidone pretreatment induced marked volume depletion, with a 2-3% reduction in body weight, a 5-10% increase in haematocrit and a 14-23% increase in plasma colloid osmotic pressure. In addition, the mean +/- SEM foot volume after both chlorthalidone (1282 +/- 37 ml) and amiloride (1289 +/- 40 ml) was lower than without pretreatment (1315 +/- 38 ml) (P < 0.05). Neither amiloride nor chlorthalidone significantly influenced the acute increase in foot volume on nifedipine. However, due to pretreatment effects, the foot volume after nifedipine was higher (P < 0.05) without pretreatment (1356 +/- 36 ml) than after amiloride (1318 +/- 38 ml) or chlorthalidone (1319 +/- 37 ml). Amiloride significantly attenuated the natriuretic effect of nifedipine, whereas chlorthalidone prevented the nifedipine-induced rise in colloid osmotic pressure and haematocrit.

CONCLUSIONS

Diuretic pretreatment and the concomitant volume depletion did not prevent acute foot swelling on nifedipine, although the absolute foot volume remained lower after such pretreatment. Therefore diuretics mitigate the oedema of CCBs, but do not directly interfere with oedema formation.

摘要

目的

尽管二氢吡啶类钙通道阻滞剂(CCB)具有利钠作用,但它们常诱发踝部水肿,这可能是由于下肢血管扩张所致。由于同时服用呋塞米并不能预防硝苯地平引起的足部体积急性增加,我们研究了利尿剂预处理是否能减轻CCB引起的足部肿胀。

方法

在四项独立实验中,10名健康志愿者接受了以下处理:(i)服用20 mg硝苯地平,无活性预处理(仅用安慰剂预处理);(ii)在每天两次服用5 mg阿米洛利治疗5天后,服用20 mg硝苯地平;(iii)在每天一次服用50 mg氯噻酮治疗5天后,服用20 mg硝苯地平;(iv)不服用活性药物(用安慰剂预处理并用安慰剂替代硝苯地平)作为对照。使用精确的排水技术测量足部体积(个体内变异系数为0.27%)。

结果

阿米洛利和氯噻酮预处理导致明显的容量减少,体重下降2 - 3%,血细胞比容升高5 - 10%,血浆胶体渗透压升高14 - 23%。此外,氯噻酮(1282±37 ml)和阿米洛利(1289±40 ml)预处理后的平均±标准误足部体积均低于未预处理时(1315±38 ml)(P<0.05)。阿米洛利和氯噻酮均未显著影响硝苯地平引起的足部体积急性增加。然而,由于预处理的影响,未预处理时硝苯地平后的足部体积(1356±36 ml)高于阿米洛利(1318±38 ml)或氯噻酮(1319±37 ml)后(P<0.05)。阿米洛利显著减弱了硝苯地平的利钠作用,而氯噻酮则预防了硝苯地平引起的胶体渗透压和血细胞比容升高。

结论

利尿剂预处理和随之而来的容量减少并不能预防硝苯地平引起的急性足部肿胀,尽管预处理后绝对足部体积仍然较低。因此,利尿剂可减轻CCB引起的水肿,但并不直接干扰水肿形成。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验